# enGene Therapeutics Inc.: filings

ENGN · Nasdaq · CIK 1980845 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/engn.md) · [Financials](/companies/engn/financials.md) · [Filings](/companies/engn/filings.md) · [Insiders](/companies/engn/insiders.md)

## Reports and events: 71 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 65, 8-K 44, 3 31, SCHEDULE 13G/A 18, 424B3 13, CORRESP 11, 10-Q 9, SC 13G 9, UPLOAD 8, SCHEDULE 13G 7, EFFECT 5, SC 13G/A 5, 424B5 4, S-8 4, 10-K 3, ARS 3, DEF 14A 3, S-3 3, SC 13D/A 3, 10-K/A 2, 425 2, 8-K/A 2, S-1/A 2, S-4/A 2, SC 13D 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, DRS 1, S-1 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 07:36 ET | [10-Q](/filings/0001193125-26-384383.md) | Quarterly report, period 2026-07-31 | 0001193125-26-384383 |
| 2026-09-08 | 07:33 ET | [8-K](/filings/0001193125-26-384380.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-384380 |
| 2026-08-11 | 16:03 ET | [8-K](/filings/0001193125-26-344559.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-344559 |
| 2026-07-17 | 16:05 ET | [8-K](/filings/0001193125-26-307795.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-307795 |
| 2026-07-16 | 08:06 ET | [8-K](/filings/0001193125-26-305418.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-305418 |
| 2026-06-18 | 16:06 ET | [8-K/A](/filings/0001193125-26-275815.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001193125-26-275815 |
| 2026-06-15 | 09:16 ET | [10-Q](/filings/0001193125-26-270386.md) | Quarterly report, period 2026-04-30 | 0001193125-26-270386 |
| 2026-06-15 | 09:14 ET | [8-K](/filings/0001193125-26-270384.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-270384 |
| 2026-06-10 | 16:09 ET | [8-K](/filings/0001193125-26-265830.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-265830 |
| 2026-05-08 | 16:06 ET | [DEF 14A](/filings/0001140361-26-020024.md) | Proxy statement, period 2026-06-09 | 0001140361-26-020024 |
| 2026-05-07 | 07:11 ET | [8-K](/filings/0001193125-26-210316.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-210316 |
| 2026-04-09 | 16:02 ET | [8-K](/filings/0001193125-26-149597.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-149597 |
| 2026-03-09 | 07:15 ET | [8-K](/filings/0001193125-26-097546.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-097546 |
| 2026-03-09 | 07:09 ET | [10-Q](/filings/0001193125-26-097541.md) | Quarterly report, period 2026-01-31 | 0001193125-26-097541 |
| 2026-03-09 | 07:04 ET | [8-K](/filings/0001193125-26-097534.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-097534 |
| 2026-02-19 | 16:15 ET | [10-K/A](/filings/0001193125-26-059409.md) | Annual report, amended, period 2025-10-31 | 0001193125-26-059409 |
| 2026-01-21 | 16:05 ET | [8-K](/filings/0001193125-26-017945.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-017945 |
| 2026-01-21 | 07:38 ET | [8-K](/filings/0001193125-26-017226.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-017226 |
| 2025-12-22 | 16:11 ET | [10-K](/filings/0001193125-25-328743.md) | Annual report, period 2025-10-31 | 0001193125-25-328743 |
| 2025-12-22 | 16:04 ET | [8-K](/filings/0001193125-25-328706.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-328706 |
| 2025-11-14 | 16:39 ET | [8-K](/filings/0001193125-25-283182.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-283182 |
| 2025-11-12 | 06:16 ET | [8-K](/filings/0001193125-25-275722.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-275722 |
| 2025-10-02 | 16:15 ET | [8-K](/filings/0001193125-25-228351.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-228351 |
| 2025-10-02 | 16:13 ET | [8-K/A](/filings/0001193125-25-228331.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-228331 |
| 2025-09-30 | 07:36 ET | [8-K](/filings/0001193125-25-224053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-224053 |
| 2025-09-11 | 16:11 ET | [10-Q](/filings/0000950170-25-114224.md) | Quarterly report, period 2025-07-31 | 0000950170-25-114224 |
| 2025-09-11 | 16:08 ET | [8-K](/filings/0000950170-25-114220.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-114220 |
| 2025-09-03 | 07:56 ET | [8-K](/filings/0000950170-25-112674.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112674 |
| 2025-07-08 | 08:09 ET | [8-K](/filings/0000929638-25-002520.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000929638-25-002520 |
| 2025-06-12 | 08:08 ET | [10-Q](/filings/0000950170-25-085143.md) | Quarterly report, period 2025-04-30 | 0000950170-25-085143 |
| 2025-06-12 | 08:05 ET | [8-K](/filings/0000950170-25-085138.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-085138 |
| 2025-06-10 | 17:26 ET | [8-K](/filings/0000929638-25-002215.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000929638-25-002215 |
| 2025-06-09 | 07:29 ET | [8-K](/filings/0000950170-25-083444.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-25-083444 |
| 2025-06-04 | 08:35 ET | [8-K](/filings/0000929638-25-002133.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000929638-25-002133 |
| 2025-05-09 | 16:05 ET | [DEF 14A](/filings/0001140361-25-018155.md) | Proxy statement, period 2025-06-10 | 0001140361-25-018155 |
| 2025-03-10 | 16:10 ET | [10-Q](/filings/0000950170-25-036281.md) | Quarterly report, period 2025-01-31 | 0000950170-25-036281 |
| 2025-03-10 | 16:07 ET | [8-K](/filings/0000950170-25-036264.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036264 |
| 2025-02-20 | 16:38 ET | [10-K/A](/filings/0000950170-25-024221.md) | Annual report, amended, period 2024-10-31 | 0000950170-25-024221 |
| 2024-12-20 | 06:59 ET | [8-K](/filings/0000950170-24-138767.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-138767 |
| 2024-12-19 | 16:22 ET | [10-K](/filings/0000950170-24-138472.md) | Annual report, period 2024-10-31 | 0000950170-24-138472 |
| 2024-12-19 | 16:09 ET | [8-K](/filings/0000950170-24-138446.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-138446 |
| 2024-11-01 | 16:04 ET | [SC 13D/A](/filings/0001193125-24-249815.md) | Ownership report, active investor, amended | 0001193125-24-249815 |
| 2024-10-25 | 08:10 ET | [8-K](/filings/0001193125-24-243481.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-243481 |
| 2024-10-21 | 08:47 ET | [8-K](/filings/0000950170-24-115767.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-115767 |
| 2024-10-18 | 16:15 ET | [SC 13D/A](/filings/0001193125-24-239641.md) | Ownership report, active investor, amended | 0001193125-24-239641 |
| 2024-09-26 | 06:33 ET | [8-K](/filings/0000950170-24-109463.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-109463 |
| 2024-09-10 | 16:38 ET | [10-Q](/filings/0000950170-24-105180.md) | Quarterly report, period 2024-07-31 | 0000950170-24-105180 |
| 2024-09-10 | 16:34 ET | [8-K](/filings/0000950170-24-105175.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-105175 |
| 2024-09-05 | 06:46 ET | [8-K](/filings/0000950170-24-103727.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-103727 |
| 2024-07-24 | 06:50 ET | [8-K](/filings/0001193125-24-183292.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-183292 |

Page 1 of 2. [Older](/companies/engn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.